121 related articles for article (PubMed ID: 3292596)
1. Epoprostenol (prostacyclin) in unstable angina.
Lichstein E; Mendizabal R; Theroux P; Muller O; Willerson JT; Rapaport E; Molk BL; Linet OI
J Clin Pharmacol; 1988 Apr; 28(4):300-5. PubMed ID: 3292596
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris.
Théroux P; Latour JG; Diodati J; Léger-Gauthier C; Morissette D; Bosch X; de Lara J; Waters D
Am J Cardiol; 1990 May; 65(16):1084-9. PubMed ID: 2109927
[TBL] [Abstract][Full Text] [Related]
3. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
[TBL] [Abstract][Full Text] [Related]
4. Treatment with prostacyclin of various forms of spontaneous angina pectoris not responding to placebo.
Szczeklik A; Nizankowski R; Szczeklik J; Tabeau J; Królikowski W
Pharmacol Res Commun; 1984 Nov; 16(11):1117-30. PubMed ID: 6395138
[TBL] [Abstract][Full Text] [Related]
5. Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial.
Gottlieb SO; Weisfeldt ML; Ouyang P; Achuff SC; Baughman KL; Traill TA; Brinker JA; Shapiro EP; Chandra NC; Mellits ED
Circulation; 1986 Feb; 73(2):331-7. PubMed ID: 3510764
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled trial of tissue plasminogen activator in unstable angina.
Nicklas JM; Topol EJ; Kander N; O'Neill WW; Walton JA; Ellis SG; Gorman L; Pitt B
J Am Coll Cardiol; 1989 Feb; 13(2):434-41. PubMed ID: 2492325
[TBL] [Abstract][Full Text] [Related]
7. Side effects of prostacyclin in patients with angina pectoris and coronary artery disease.
Galvani M; Bugiardini R; Ferrini D; Gridelli C; Mari L; Puddu P; Lenzi S
Ric Clin Lab; 1985; 15(2):145-9. PubMed ID: 3903957
[TBL] [Abstract][Full Text] [Related]
8. Epoprostenol sodium (prostacyclin) infusion in acute myocardial infarction.
Kiernan FJ; Kluger J; Regnier JC; Rutkowski M; Fieldman A
Br Heart J; 1986 Nov; 56(5):428-32. PubMed ID: 3539163
[TBL] [Abstract][Full Text] [Related]
9. Intravenous prostacyclin in acute nonhemorrhagic stroke: a placebo-controlled double-blind trial.
Hsu CY; Faught RE; Furlan AJ; Coull BM; Huang DC; Hogan EL; Linet OI; Yatsu FM
Stroke; 1987; 18(2):352-8. PubMed ID: 3551212
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of intravenous prostacyclin in stable angina pectoris.
Firth BG; Winniford MD; Campbell WB; Hillis LD
Am J Cardiol; 1983 Sep; 52(5):439-43. PubMed ID: 6351580
[TBL] [Abstract][Full Text] [Related]
11. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
Circulation; 1997 Sep; 96(5):1445-53. PubMed ID: 9315530
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of a prostacyclin-sparing aspirin formulation and heparin/warfarin in aspirin users with unstable angina or non-Q wave myocardial infarction at rest. The Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
Cohen M; Parry G; Adams PC; Xiong J; Chamberlain D; Wieczorek I; Fox KA; Kronmal R; Fuster V
Eur Heart J; 1994 Sep; 15(9):1196-203. PubMed ID: 7982419
[TBL] [Abstract][Full Text] [Related]
13. Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial.
Topol EJ; Nicklas JM; Kander NH; Walton JA; Ellis SG; Gorman L; Pitt B
Am J Cardiol; 1988 Sep; 62(7):368-71. PubMed ID: 2970776
[TBL] [Abstract][Full Text] [Related]
14. Unstable angina: status of aspirin and other forms of therapy.
Lewis HD
Circulation; 1985 Dec; 72(6 Pt 2):V155-60. PubMed ID: 3905054
[TBL] [Abstract][Full Text] [Related]
15. A double blind study of prostacyclin in cardiopulmonary bypass surgery.
Walker ID; Davidson JF; Faichney A; Wheatley DJ; Davidson KG
Br J Haematol; 1981 Nov; 49(3):415-23. PubMed ID: 6457624
[TBL] [Abstract][Full Text] [Related]
16. Variables predictive of successful medical therapy in patients with unstable angina: selection by multivariate analysis from clinical, electrocardiographic, and angiographic evaluations.
Ouyang P; Brinker JA; Mellits ED; Weisfeldt ML; Gerstenblith G
Circulation; 1984 Sep; 70(3):367-76. PubMed ID: 6378422
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
18. Double-blind controlled trial of the therapeutic effects of prostacyclin in patients with completed ischaemic stroke.
Huczynski J; Kostka-Trabka E; Sotowska W; Bieron K; Grodzinska L; Dembinska-Kiec A; Pykosz-Mazur E; Peczak E; Gryglewski RJ
Stroke; 1985; 16(5):810-4. PubMed ID: 3901421
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin for acute coronary insufficiency.
Szczeklik A; Szczeklik J; Nizankowski R; Głuszko P
Artery; 1980; 8(1):7-11. PubMed ID: 6775619
[TBL] [Abstract][Full Text] [Related]
20. Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo.
Freeman MR; Langer A; Wilson RF; Morgan CD; Armstrong PW
Circulation; 1992 Jan; 85(1):150-7. PubMed ID: 1728444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
